Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-06 in Patients With Pain Associated With Acute Herpes Zoster
NCT05480553Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes zoster (HZ) comparing NPC-06 with Placebo (2 arms). Primary endpoint: Change of Numeric Rating Scale Score at 120 minutes. Started Aug 2022; status: completed.
02
Drugs
fosphenytoin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05480553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480553.